January 2004

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-01-02-2004
Volume 28
Issue 1

Pharmaceutical science and technology news

External Link - article-84230.pdf

Articles in this issue
Coprocessed Excipients for Solid Dosage Forms
Manufacturing Execution Systems
State-of-the-Art Packaging Machines
January 2004
Medicare Bill Contains Significant Changes for Drug Manufacturers
The Bioterrorism Act
Establishing and Maintaining an Effective Gas Evaluation and Management Program
New Supply-Chain Dynamics
In the Spotlight--February 2004
January 2004
Recent Videos
Industry Outlook 2025: Business Viability and Global Collaboration
Industry Outlook 2025: Business Viability and Global Collaboration
Industry Outlook 2025: Large Language Models
Industry Outlook 2025: Large Language Models
Drug Digest: Strategic Partnerships
Drug Digest: Strategic Partnerships
Behind the Headlines: Episode 13; Budget Cuts, Reshoring, and Biotech Buyouts
Behind the Headlines: Episode 13; Budget Cuts, Reshoring, and Biotech Buyouts
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Industry Outlook 2025: Continuing Innovation
DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing
DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing
DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
DCAT Week 2025: Enzymatic RNA Synthesis
DCAT Week 2025: Enzymatic RNA Synthesis
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
DCAT Week 2025: Gaining End-to-End Clarity
DCAT Week 2025: Keeping Up with Drug Demand
DCAT Week 2025: Keeping Up with Drug Demand
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

FDA CBER Director Peter Marks Resigns

Susan Haigney
March 31st 2025
Article

Marks called out an ‘assault’ on truth and science in his resignation letter, which has sent the bio/pharmaceutical industry reeling.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

EMA Recommends Five New Medicines for Approval

Patrick Lavery
March 28th 2025
Article

Three of the five are biosimilars, and seven additional medicines received recommendations for indication extensions.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Novotech Named Best Australian CRO at Asia-Pacific Biopharma Excellence Awards

Patrick Lavery
March 28th 2025
Article

Winners are selected entirely through industry voting, with those honored representing recognition by their peers.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Issues Warning Letter to Aspen Biopharma Labs for API Manufacturing Deviations

Feliza Mirasol
March 27th 2025
Article

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.